USA Mutuals Advisors’s Neurogene NGNE Stock Holding History

USA Mutuals Advisors’s Portfolio NGNE Stock Details NGNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-13	Closed	-$2K	–	154
2015 Q2	$2K	Buy	+13	New	+$1.98K	﹤0.01%	96

Other funds holding NGNE

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

First Manhattan

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

USA Mutuals Advisors's NGNE Position: Q3 2015 in Review

USA Mutuals Advisors sold out of Neurogene (NGNE) in Q3 2015, closing a stake of 13 shares — an estimated $2K sold.

USA Mutuals Advisors first reported a position in NGNE in Q2 2015 and held it in 1 quarter. The position peaked at $2K in Q2 2015. 33 funds tracked by Wall St. Rank hold NGNE as of Q3 2015.

USA Mutuals Advisors reported no remaining Neurogene position as of Q3 2015 after selling out during the quarter.
USA Mutuals Advisors sold 13 Neurogene shares in Q3 2015, an estimated $2K.
USA Mutuals Advisors first reported a position in Neurogene in Q2 2015 and held it in 1 quarter.
USA Mutuals Advisors's Neurogene position peaked at $2K in Q2 2015.
33 funds tracked by Wall St. Rank held Neurogene as of Q3 2015.

Based on USA Mutuals Advisors's 13F filing for Q3 2015, filed 12 Nov 2015.